Grossmann, Mathis http://orcid.org/0000-0001-8261-3457
Fui, Mark Ng Tang http://orcid.org/0000-0002-5101-8572
Nie, Tian http://orcid.org/0000-0001-7426-0356
Hoermann, Rudolf http://orcid.org/0000-0002-1326-4270
Clarke, Michele V.
Cheung, Ada S. http://orcid.org/0000-0001-5257-5525
Zajac, Jeffrey D. http://orcid.org/0000-0003-3933-5708
Davey, Rachel A. http://orcid.org/0000-0001-5121-0209
Funding for this research was provided by:
Bayer
Article History
Received: 4 November 2020
Accepted: 30 March 2021
First Online: 17 April 2021
Compliance with ethical standards
:
: M.G. has received research funding from Bayer, Novartis, Weight Watchers, Lilly and speaker’s honoraria from Besins Health Care. M.N.T.F. has received research funding from Bayer Pharma. T.N., R.H., J.D.Z. and R.D. have nothing to disclose.
: All participants in the fat biopsy sub-study were required to sign an additional Participant Information and Consent Form (PICF) specifically dedicated to the fat biopsy sub-study explaining the purpose and risks of taking subcutaneous fat biopsies.
: Human Research Ethics Committee, Austin Health (HREC 2012/04495).